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Abstract: Surfactins are cyclic lipopeptides consisting of a β-hydroxy fatty acid of various chain
length and a peptide ring of seven amino acids linked together by a lactone bridge, forming the
cyclic structure of the peptide chain. These compounds are produced mainly by Bacillus species and
possess numerous biological effects such as antimicrobial (antiviral, antibacterial, and antifungal)
activities. A mixture of surfactins extracted from Bacillus subtilis strain SZMC 6179J was examined by
HPLC-ESI-IT-MS technique, enhancing their separation to reveal novel lipopeptide varieties with
higher masses and to characterize their structures. During the MS2 spectra analyses of their sodiated
molecular ions [M + Na]+, a previously rarely encountered group of surfactins was detected and two
novel types of the group were discovered containing methyl esterified aspartic acid residue in their
fifth amino acid position. The relative amounts of these monomethyl isoforms exceeded 35% of the
produced surfactin in total. In the m/z value of 1114, all the detected isoforms possessed aspartic acid
4-methyl ester residue in their fifth amino acid position (C17-[Lxx4, AME5], C18-[AME5]), offering
an opportunity to separate a pure fraction of the compound and to study its biological activities in
the future.
Keywords: Bacillus; cyclic lipopeptides; HPLC-ESI-IT-MS; surfactin
1. Introduction
Surfactins are cyclic lipopeptide-type biosurfactants produced mainly by Bacillus subtilis,
a Gram-positive bacterium [1]. It consists of a hydrophobic β-hydroxy fatty acid chain of various
length (C12–C15) linked to a ring of seven amino acids (Figure 1). The cyclic structure is formed by
a lactone bridge between the β-hydroxyl functional group of the fatty acid and the C-terminal of
the heptapeptide [2]. Because of its potent surface activity properties [2], surfactin exhibits various
biological activities such as antiviral, antitumor, and antimicrobial effects [3], which makes this
heptapeptide the subject of various environmental, industrial, and therapeutical investigations [4,5].
The length of the fatty acid chain and the amino acid sequence varies, resulting in numerous isoforms
of the compound listed and characterized in previous works [2] (Table 1). Although most of these
variants were reported in the 1990s, a recent study from our group introducing a novel surfactin
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molecule containing Val in the second amino acid position [6] (Figure 1) proved that there may still
be surfactin isoforms that are yet to be discovered. Moreover, the incorporations of esterified form
of Asp (Asp-O-Me, aspartic acid 4-methyl ester—AME) and Glu (Glu-O-Me, glutamic acid 5-methyl
ester—GME) were also reported occasionally [7–9]. In the present study, an HPLC gradient elution
method was applied that was capable of separating all lipopeptide components in our sample and to
examine the separated, previously hidden, more non-polar fractions by MS2 measurements in order to
identify the various surfactin molecules, with different amino acid sequences and aliphatic acid chain
lengths, produced by B. subtilis SZMC 6179J to the full extent.
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Figure 1. The structure of the surfactin variant [Val2] described by Bóka et al. [6]. R = C3H7–C5H11.
Table 1. Natural surfactin peptide sequence variants including the recently found isoforms containing
AME in the fifth position.
Nomenclature of Surfactin Peptide References
AA1 AA2 AA3 AA4 AA5 AA6 AA7
[Sur] surfactin Glu Leu e Val Asp Leu Leu [10]
[Val2] surfactin Glu Val xx Val Asp Lxx Lxx [6]
[Ala4] surfactin Glu Leu Ala Asp Leu Leu [11]
[Leu4] surfactin Glu Leu Leu Asp Leu Leu [12]
[Ile4] surfactin Glu Leu Ile Asp Leu Leu [12]
[Ile2,4] surfactin Glu Ile Ile Asp Leu Leu [13]
[Val7] surfactin Glu Leu al Asp Leu Val [14,15]
[Ile7] surfactin Glu Leu al Asp Leu Ile [14]
[Val2,7] surfactin Glu Val al Asp Leu Val [13]
[Val2, Ile7] surfactin Glu Val Val Asp Leu Ile [16]
[Ile2, Val7] surfactin Glu Ile al Asp Leu Val [16]
[Ile2,4,7] surfactin Glu Ile Ile Asp Leu Ile [13]
[GME1,AME5] surfactin GME Leu al AME Leu Leu [7]
[GME1,Val7] surfactin GME Leu al Asp Leu Val [7]
[GME1, Ile7] surfactin GME Leu eu al Asp Leu Ile [7]
[AME5] surfactin Glu Leu eu Val AME Leu Leu [8]
[AME5,Val7] surfactin Glu Lxx Lxx Val AME Lxx Val This study
[Lxx4, AME5] surfactin Glu Lxx Lxx Lxx AME Lxx Lxx This study
GME—glutamic acid 5-methyl ester, AME—aspartic acid 4-methyl ester.
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2. Results and Discussions
2.1. Separation of Lipopeptides
The starting point for the separation of lipopeptides was our previous study, where isocratic
separations were applied [6] based on the method described by Akpa et al. [17]. Within the isocratic
elution of the water/acetonitrile mixture (20:80, v/v), the surfactins with identical molecular weights
eluted in well-defined time windows according to their polarities and increased molecular masses
in the following order: m/z 1016, 15–27 min; m/z 1030, 16–36 min; 1044 m/z, 23–44 min; 1058 m/z,
31–55 min. This method allowed the detection of surfactins up to m/z 1058, but the last lipopeptide
(C16-[Val7]) already eluted near to the end of the isocratic chromatographic run, suggesting the
presence of other surfactin molecules with higher molecular weight [6]. The previously separated
and identified isoforms represented three types of known surfactin variants and a fourth, previously
unknown, group, which was characterised by the replacement of the leucine residue by valine in
the amino acid position 2. Therefore, it was assumed that the prolonged separation is able to lead
to gather mass spectrometric information about the possible novel surfactin variants eluted later.
The introduction of the gradient separation resulted in a complete elution of the whole surfactins
according to the chromatograms (Figure 2). The extracted ion chromatograms of 1016–1058 m/z
values show the previously discussed surfactins (Figure 2a), and also, new peaks appeared with high
intensities within the range of m/z 1072–1114 (Figure 2b), showing a 14 Da mass difference from the
formerly described molecules and from each other.
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Figure 2. The extracted ion chromatograms of m/z 1016–1058 (a) and m/z 1072–1114 (b).
The peaks on Figure 2a cover the earlier reported surfactin varieties [6]. According to these, the 1,
3–7, 11–14, 18–21, 25–28, and 34–35 correspond to the C13-, C14-, C15-, and C16-[Val7], while the 2 to
the C13 -[Val2]; the 8 to the C14-[Val2,7]; and finally the 9–10, 15–17, 22–24, 30, and 37 mark the C13-,
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C14-, C15-, C16-, and C17-[Sur] surfactin molecules, respectively (Supplementary Materials Figures
S1–S49). These variants were already described and characterized in detail based on their MS analysis
and MS2 patterns [6]; thus, our study focused on the newly detected forms that appeared in the higher
m/z range and eluted at the end of chromatographic run.
The 21 molecules that appeared in the m/z range of 1072–1114 (29–49) have not been characterized
in our previous work using isocratic separations, thus their identification is needed using MS2
fragmentations (Figure 2b, Table 2). The mass deviations following the sequence of known surfactin
m/z values lead to the implication that these compounds may be the formerly characterized surfactin
isoforms containing longer fatty acid chains, possibly increasing even to a length of 21 carbon atoms
in the m/z value of 1114 (C21-[Val2,7]). In order to test this hypothesis, the MS2 analyses of the
21 possible surfactin components were conducted, whose m/z values were in the higher mass range
(m/z 1072–1114). It is important to consider that surfactins possessing 1128 m/z value were not
detectable at all using the MS mode of analysis and the absence of this m/z value was also confirmed
later by the MS2 measurements.
2.2. Analysis of the MS2 Spectra of Surfactins Over m/z 1058
The results of the MS2 analyses are demonstrated on the spectrum of the first eluted peak (29) of
the extracted ion chromatogram with the m/z value of 1072 (Figure 3), while the MS2 spectra of the
other examined components are in the Supplementary Material (Figure S1–S49). Based on the MS2
investigations, all the above mentioned 21 components are proven to be members of the surfactin
group of the lipopeptide family. The MS2 spectra, originating from the fragmentation of sodiated
surfactin molecules, could generally show three types of characteristic fragment ion series, which
were characterized in detail in our previous study [6]. Briefly, the fragments appearing on the MS2
spectra recorded by the ion trap analyser could have resulted from the simple cleavage [18], internal
fragmentation [6], and from McLafferty rearrangement [19] mechanisms.
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Figure 3. The characteristic fragment ions of C16-[Sur] (m/z 1072, 30; (A)) and C15-[AME5]
(m/z 1072, 29, (B)) resulting via simple cleavage mechanism. AME means the aspartic acid 4-methyl
ester residue.
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In the first case, the series of fragment ions are formed when the lactone bridge connecting
the C-terminal amino acid to the hydroxyl group of the fatty acid is opened by heterolytic cleavage
of the bond between the sodiated oxygen atom and the carbonyl carbon atom. Then, successive
eliminations of C-terminal amino acid residues produce a series of N-terminal fragments named b6,
b5, and b4 [2,6]. Furthermore, the appearance of the b50 ions were also observed, originating from the
loss of water from the carboxyl group linked to the side chain of the acidic amino acid in the sequence,
which commonly occurs in the case of N-terminal Glu residue [20]. It is important to consider that
these fragments also contain the whole fatty acid part of the molecules besides the peptide sequence
fragment. With the decrease in the length of the peptide chain, the intensities of these b series daughter
ions were also reduced, such as the intensities of b4 and b3-type ions ranging only from 1–25% and
0–3%, respectively. The mass differences between these ions led to the identification of at least the
three ending residues of the lipopeptides, including AA7, AA6, and AA5, but in certain cases, the AA4
was also able to characterize (Table 1). Furthermore, a characteristic neutral loss was also detected
within the series of the simple cleavage ions on the MS2 spectra of each components, with the same
mass differences (46 Da) from b6, b5, and b4 ions. This frequently appearing neutral loss could have
originated either from the side chain carboxylic functions (H2O + CO) [21] or from the bn − an (28 Da)
transformation and an additional water loss (18 Da), which could be marked as an0 transformed from
the bn0 (Figure 3).
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(m/z 1072, 29, (B)) resulted via internal fragmentation mechanism.
During the spectral evaluation of the surfactin components, in certain cases, extraordinary mass
differences were observed between the b5 and b4 fragment ions, which indicated that there is a
possibility for the replacement of the common Asp amino acid residue in the fifth position at certain
surfactin variants. This observation led to the detection of the monomethyl ester surfactins containing
AME instead of Asp in the fifth position of the peptide chain according to the detected mass difference
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between the b-series ions (Figure 3) [9]. This difference of the fragmentation patterns could be compared
with each other between the [Sur] and the [AME5] type surfactins possessing same molecular weight
(Figure 3). On the MS2 spectra resulting from the fragmentation of m/z 1072, it is obvious that the
variances in the molecules are in the peptide sequences at the b4 fragment ions, which is m/z 731
(b5-115 Da) and m/z 717 (b5-129 Da) for [Sur] and [AME5], respectively. This observation also led to
the discovery of a novel type of components within the surfactin lipopeptide family containing also
AME instead of Asp in the fifth position, as well as Lxx in the fourth position ([Lxx4,AME5]) or Val
in the seventh position ([AME5,Val7]). To the best of our knowledge, this is the first report on the
existence of this type of surfactin molecules.
The second series of fragments appeared at smaller m/z values, because they do not contain the
fatty acid chain part of the molecule as well as the N-terminal Glu residue, only the internal parts of
the heptapeptide of the surfactin molecules (Figure 4, Table 2). These fragments were formed via the
double hydrogen transfer mechanism, which suggest the opening of the ring at the ester side causing
the additional water increase on the y6 and y6bm (m ≤ 6) ions [6,22]. The major fragment of this group
is represented by the y6 + H2O and the following members derived from this major fragment ion by
the same consecutive elimination of C-terminal amino acids, as in the case of the simple cleavage
described above, thus represented as y6b6 + H2O and y6b5 + H2O [6].
Table 2. Characteristic ions of the different surfactin isoforms found in the sample from the
fragmentation of m/z 1072, 1086, 1100, and 1114.
Precursor Ion
[M + Na]+
(m/z)
Peak No. Name Simple Cleavage McLafferty Fragments Internal Fragments
b6 b5 b50 b4 [M+Na]+-72 b50-72 y6+H2O y6b6+H2O y6b5+H2O
1072
30 C16-[Sur] 959 846 828 731 1000 756 707 594 481
34–35 C17-[Val7] 973 860 842 745 1000 770 693 594 481
29, 31 C15-[AME5] 959 846 828 717 n.d. 756 721 608 495
32–33 C16-[AME5,Val7] 973 860 842 731 1000 n.d. 707 608 495
1086
37, 39 C17-[Sur] 973 860 842 745 1014 770 707 594 481
36, 38 C16-[AME5] 973 860 842 731 n.d. n.d. 721 608 495
40 C17-[AME5,Val7] 987 874 856 745 n.d. n.d. 707 608 495
1100
41–43 C17-[AME5] 987 874 856 745 n.d. n.d. 721 608 495
44–45 C18-[AME5,Val7] 1001 888 870 759 n.d. n.d. 707 608 495
1114
46 C17-[Lxx4,AME5] 1001 888 870 759 n.d. n.d. 735 622 509
47–49 C18-[AME5] 1001 888 870 759 n.d. n.d. 721 608 495
n.d.: not detected.
Examining the m/z values of the internal fragment ions, two fragments are additionally important
for the confirmation of the existence of the AME in the fifth position of the peptide sequence. The first
is the m/z value of the y6 + H2O fragment representing sum mass of the last six C-terminal amino
acids, while the second is the mass difference of this fragment ion from the precursor ion (sodiated
adduct) resulting in the length of the linked fatty acid chains. This characteristic fragment ion and
14 Da deviation between the surfactins containing Asp5 or AME5 could be compared on their spectra
(Figure 4). In the case of Figure 4B, the 14 Da mass increase of y6 + H2O suggests that the fatty acid
chain of 29 molecule consists of 15 carbon atoms, while the 30 contain C-16 fatty acid residue (Figure 4).
Therefore, the knowledge of the two C-terminal amino acids from the simple cleavage fragmentation
pattern (both Lxx for 29 and 30) and the peculiar shift in the mass of y6b4 + H2O fragment ions could
have only originated from the deviation in the amino acid sequence between the second and the fifth
(AA2–AA5) positions of the sequence. On the other hand, a major confirmatory argument would also
be the presence of y6b4 + H2O fragment ions, but it was not visible on the MS2 spectra recorded with
the applied ion trap mass spectrometric analyzer. However, it could be concluded that the examination
of the presence of b4 and y6 + H2O fragment ions on the MS2 spectra of surfactins, as well as their
relationship with the sodium adduct precursor ion masses, comprehensively determine the alteration
of the Asp to AME in the AA5 position in this type of surfactins.
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The third series of fragments resulted from intraresidual McLafferty rearrangement, where the
hydrogen at the γ-carbon atom from the N-terminal Glu residue transfers to its carbonyl oxygen causing
the cleavage of the link inside the amino residue between the αC–βC atoms. These rearrangements
could usually be measured related to the surfactins as a mass difference of 72 Da from both the sodiated
precursor ion and the b50 on the product ion spectra [6]. These neutral losses were detected in all cases
in the lower m/z region up to m/z 1030, while it completely missed in the highest m/z region ranged
from m/z 1086 (Table 2, Figure S1–S49). Thus, it seems to be that the presence or absence of the neutral
loss originating from the McLafferty rearrangement depends mainly on the length of the linked fatty
acid chain.
Using the above-mentioned rules, the MS2 spectra of each suspected surfactin molecule were
also analysed. Each surfactin compound in the higher mass range (m/z > 1058) was identified based
on the MS2 spectra of all detected peaks of the extracted ion chromatograms and the mentioned
considerations. Altogether, three types of surfactins were recognized containing AME at the fifth
position including [AME5], [Lxx4, AME5], and [AME5, Val7]; neither the GME monomethyl isoforms
nor the dimethyl isomorfs were detected. The characteristic ions of the simple cleavages and the
internal fragments, as well as the McLafferty rearrangement related to the different isoforms, are shown
in Table 2 and their MS2 spectra are in the Supplementary Material (Figure S1–S49). The surfactins with
lower masses (m/z < 1072) produced by the B. subtilis SZMC 6179J strain, as well as their structural
elucidations, were published in our previous report [6]. The MS2 fragmentation of 1128 m/z value was
also carried out in a separated chromatographic run, but no fragments were detected supporting the
absence of this surfactin variant.
2.3. Characterization of the Amount of Produced Surfactin
Observing the results provided by the MS2 analyses of the sodiated surfactin molecules led us to
the conclusion that the examined B. subtilis strain produced relatively high amounts of the different
isoforms in total. In certain cases, an accurate gas chromatographic method could be applied for
the quantitation of surfactins. This approach was capable of simultaneously measuring both the
derivatized fatty acid chain and amino acids after the hydrolysis of the surfactins [23]. However,
because of the high complexity of our sample, the relative quantities of the variants found in the
sample extract were expressed as percentages of the total surfactin content based on the areas of their
sodiated aducts ([M + Na]+) estimating their relative amounts semi-quantitatively. The ionization
efficiency in the used ion source may vary along the different variants, but it could provide useful
information about the approximate proportions of their amounts, as most of the variants have not yet
been isolated in pure form and the analytical reference standards are not available.
To compare the relative quantity of the isoforms containing an AME residue with the other
variants previously found and characterized from samples of strain SZMC 6179J, the ratio of the
integrated areas of sodiated molecular ions in full scan MS mode of both the previously reported lower
m/z region and the ones described in the present work bearing higher m/z values were represented
in a diagram (Figure 5). The presence of these monomethyl isoforms is not negligible by any means,
altogether having an area ratio of 36%; this sum exceeds the amount of the first discovered surfactin
molecule ([Sur], 25%), which is considered to be the most common variant. The appearance of Val in
the seventh position is the most dominant, 54% of the compounds possess this change in the amino
acid sequence, while the presence of Val in the second and Leu in the fourth position occurs in less
than 1% in both cases.
To examine the ratios of the different fatty acid chain lengths of the produced compounds, their
areas were also compared (Figure 6). This excludes the previously suggested possibility of an isoform
having a 21 carbon atom long chain in our sample, and also shows the longest fatty acid chain as
C18 in about 7% of the total amount of surfactin, extending the carbon chain length suggested by
Bonmatin et al. [2] to 15. Although Bóka et al. [6] found the C16-[Val7] variant of surfactin in a mere
3% relative amount, the introduction of our modified gradient program enabling the separation of
Molecules 2018, 23, 2224 8 of 12
component ions of higher masses increased the ratio of C16 compounds to 22%, not to mention the
fact that 47% of the surfactin molecules found in our sample bears an aliphatic chain length of 16 or
more carbon atoms.
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For the full perception of the spectrum of the surfactin molecules found in our sample,
a summarizing diagram was prepared (Figure 7). It reveals the reason why the [AME] variants
have rarely been found before, as their fatty acid chain lengths range from C15 to C18, which means
that their sodiated ion masses are 1072–1114 Da, respectively. The chromatographic parameters applied
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before did not allow the separation of these fractions, which also explains the low relative amount
of the C16-[Val7] isoform found by Bóka et al. [6], although according to our recent examinations,
this variant is produced in the highest amount by B. subtilis SZMC 6179J. The surfactin molecules being
the most diverse regarding the aliphatic chain lengths are the [Sur] and the [Val7] variants, both with
five different homologues ranging from C13 to C17, while only the ones containing an AME residue in
their fifth amino acid positions ([AME5] and [AME5, Val7]) have the C18 homologue.
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3. Materials and Methods
3.1. Chemicals and Reagents
All solvents and reagents were analytical or the highest grade available. Hydrochloric
acid, methanol, and acetonitrile were purchased from VWR International (Budapest, Hungary).
Trifluoroacetic acid (TFA) was purchased from Sigma Aldrich (Budapest, Hungary). HPLC grade
water with a resistivity of 18 MΩ was produced by ultrafiltration with a Millipore Milli-Q Gradient
A10 water purification system (Merck, Budapest, Hungary).
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3.3. Extraction of Surfactins
The bacterial cells were separated from the ferment broths via centrifugation at 8000 g for 10 min.
The pH of the supernatant was decreased to 2 with HCl and the lipopeptides were precipitated
overnight at 4 ◦C. The pellets were collected by centrifugation (10,000 g, 10 min) and resolved in 3 mL
methanol [6].
3.4. Liquid Chromatography–Mass Spectrometry Analysis
Surfactin homologues extracted from the B. subtilis strain SZMC 6179J were identified by
HPLC-ESI-IT-MS. Gradient RP-HPLC elution was carried out on a Phenomenex Prodigy analytical
column (100 × 2.0 mm, 3 µm; Gen-Lab, Budapest, Hungary) with an Agilent 1100 Series HPLC
system (Palo Alto, CA, USA) equipped with a binary pump, a vacuum degasser, and a µWell-plate
autosampler. The columns were thermostated at 35 ◦C using a model 7990 Space column heater
(Jones Chromatography, Hengoed, UK). The gradient solvent-delivery system consisted of two solvents,
A was H2O and B was a mixture of acetonitrile/methanol (1:1, V/V %), both solvents supplemented
with 0.05% TFA. The gradient elution was applied at a flow rate of 250 µL/min and was started
with 47% of eluent B for 12 min and increased linearly to 95% at 92 min, where value was held for
16 min and then decreased to the initial 15% in two minutes, and remained constant until the pressure
stabilized ending the run of 120 min in total. The injection volume was 3 µL.
The MS and MS2 analyses were performed on a 500-MS ion trap mass spectrometer (Agilent,
Palo Alto, CA, USA) equipped with an ESI source in positive mode based on our previous study [6].
The utilized ESI parameters were as follows: spray chamber temperature, 50 ◦C; drying gas (N2)
pressure and temperature, 30 psi and 350 ◦C, respectively; nebulizer gas (N2) pressure, 50 psi; needle
voltage, 5000 V; spray shield voltage, 600 V. The general parameters were as follows: maximum scan
times, 1.51 s/scan; scans averaged, 2 µscans; data rate, 0.66 Hz; multiplier offset, 0 V. Ionization
control parameters were as follows: target TIC, 100%; max ion time, 250,000 µseconds. The full scan
parameters were as follows: capillary voltage, 231.3 V; RF loading, 68%; low mass, 100 m/z; high mass,
2000 m/z.
The MS2 measurements on the sodium adducts of the molecules were also achieved using the
same ESI source and general MS parameters mentioned above. In the case of MS2 measurements,
for the 1016, 1030, 1044, 1058, 1072, 1086, 1100, 1114, and 1128 m/z values, the following excitation
storage level (m/z) /excitation amplitude values were applied: (V) 273.5/3.91, 277.4/9.96, 281.3/4.02,
285.3/4.07, 289.3/4.12, 293.3/4.17, 297.4/4.22, 301.5/4.27, and 305.6/4.32, respectively. Each m/z value
of the sodium adducts was monitored alone in separated chromatographic runs to avoid the possible
cross-talk effects in the mass analyser.
3.5. Nomenclature
Surfactin isoforms were designated according to Grangemard et al. [13] and Bóka et al. [6]. Briefly,
the first discovered surfactin sequence (Glu-Leu-Leu-Val-Asp-Leu-Leu) was denoted as [Sur] and any
changes in the peptide sequence were indicated with the abbreviation and position of the altered
amino acid, for example, [Val2], [Val7], and [Val2,7]. The esterified form of aspartic acid and glutamic
acid at the side chain carboxyl group were abbreviated as AME and GME, respectively. As the applied
mass spectrometric technique could not distinguish between the Leu and Ile isobaric residues, this
sequence element was marked as Lxx in this paper. The amino acid residues present in the sequences
of the surfactins are designated in general by AAn, the superscript ‘n’ indicating the position number of
each amino acid from the N-terminal end of the peptide chain. Furthermore, the fragment ions on the
MS2 spectra were designated according to the terminology published by Roepstorff and Fohlman [26],
as well as Biemann [27], while the internal fragments of sodiated fragment ions were designated by
the ynbm nomenclature [6,22].
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4. Conclusions
We developed an efficient HPLC gradient elution to effectively separate the fractions of surfactin
produced by B. subtilis in the higher range of m/z values. When the structures of these compounds with
greater masses were examined by MS2 analyses, isoforms of surfactin molecules containing AME in
their fifth peptide position were recognized, also involving the newly described types ([Lxx4,AME5],
[AME5,Val7]). After the study of the MS2 spectra validated our suggestions regarding the amino acid
sequence, we calculated and compared the ratios of the produced surfactin isoforms. The results of
these semi-quantitative comparisons proved the presence of these variants to be remarkable amount.
In the case of the highest m/z values (at m/z 1100 and 1114), only these new isoforms possessing
AME5 could be detected and the formation of C18-[AME5] had a yield close to 100%, thus posing the
possibility of a facilitated selective separation of the novel isoform closest to the firstly discovered
surfactin in structure; therefore, its biological effects can be characterized in comparison to its most
extensively studied variants.
Supplementary Materials: The following are available online, Figures S1–S49.
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